Location History:
- West Harbour, NZ (2009)
- Auckland, NZ (2008 - 2022)
Company Filing History:
3 out of 263 
1 out of 251 
Years Active: 2008-2022
Title: The Innovative Contributions of Lai-Ming Ching
Introduction
Lai-Ming Ching is a prominent inventor based in Auckland, New Zealand. She has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer therapies. With a total of four patents to her name, her work has the potential to impact cancer treatment significantly.
Latest Patents
Lai-Ming Ching's latest patents include innovative pharmaceutical compositions that target tryptophan dioxygenases (IDO1 and TDO). These compositions comprise 3-aminoisoxazolopyridine compounds that exhibit IDO1 and/or TDO inhibitory activity. The methods described in her patents offer new avenues for treating various conditions, including cancer. Another notable patent involves an anti-cancer composition that utilizes DMXAA or related compounds for gastrointestinal administration. This invention emphasizes the importance of delivering the compound effectively to the site of action in patients, enhancing the treatment's efficacy.
Career Highlights
Throughout her career, Lai-Ming Ching has worked with reputable organizations such as Cancer Research Technology Limited and Auckland Uniservices Limited. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to significant advancements in cancer research.
Collaborations
Lai-Ming Ching has collaborated with notable individuals in her field, including Bruce Charles Baguley and Philip Kestell. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Lai-Ming Ching's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight her role as a leading inventor in her field. Her patents and collaborations reflect her commitment to advancing medical science and improving patient outcomes.